We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cambridge Cognition Holdings PLC | AQSE:COG.GB | Aquis Stock Exchange | Ordinary Share | GB00B8DV9647 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 54.50 | 51.00 | 58.00 | 54.50 | 54.50 | 54.50 | 0.00 | - |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMCOG
Cambridge Cognition Holdings PLC
31 May 2023
31 May 2023
Cambridge Cognition Holdings Plc
("Cambridge Cognition" or the "Company")
Capital Markets Day
Cambridge Cognition Holdings plc ("the Company"), which develops and markets digital solutions to assess brain health, is pleased to announce that it will be hosting a Capital Markets Day on 14 June 2023 at 14:00 in the Great Room at Central Court, 25 Southampton Buildings, London WC2A 1AL.
The event will feature a series of presentations from Cambridge Cognition's management and senior leadership team focussing on the latest developments in the Company's product and technology portfolios.
To express interest in attending the event please email: cog@investor-focus.co.uk
No material new information or update on current trading will be disclosed at the event.
Enquiries:
Cambridge Cognition Holdings Plc Tel: 012 2381 0700 Matthew Stork, Chief Executive Officer press@camcog.com Stephen Symonds, Chief Financial Officer Panmure Gordon (UK) Limited (NOMAD and Joint Broker) Tel: 020 7886 2500 Freddy Crossley / Emma Earl / Mark Rogers (Corporate Advisory) Rupert Dearden (Corporate Broking) Dowgate Capital Limited (Joint Broker) Tel: 020 3903 7715 David Poutney / James Serjeant IFC Advisory Limited (Financial PR and Tel: 020 3934 6630 IR) cog@investor-focus.co.uk Tim Metcalfe / Graham Herring / Zach Cohen
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit www.cambridgecognition.com
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAWPUCCAUPWGQU
(END) Dow Jones Newswires
May 31, 2023 02:00 ET (06:00 GMT)
1 Year Cambridge Cognition Chart |
1 Month Cambridge Cognition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
